APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multiplex Immunofluorescence (mIF) Technology

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Multiplex Immunofluorescence (mIF) Technology Industry Growth and Trends Forecast to 2032

5 March 2026100 pages

Choose your research edition.

Industry ResearchMultiplex Immunofluorescence (mIF) Technology Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Multiplex Immunofluorescence (mIF) Technology Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Multiplex Immunofluorescence (mIF) Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multiplex Immunofluorescence (mIF) Technology Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Multiplex Immunofluorescence (mIF) Technology Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Multiplex Immunofluorescence (mIF) Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Multiplex Immunofluorescence (mIF) Technology is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Multiplex Immunofluorescence (mIF) Technology is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multiplex Immunofluorescence (mIF) Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Multiplex Immunofluorescence (mIF) Technology market include Eureka Biotech, ICON plc, Discovery Life Sciences, Precision Medicine Group, Terry Technologies, MGI Tech, panovue, Biospective and iCuraDx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Multiplex Immunofluorescence (mIF) Technology market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Multiplex Immunofluorescence (mIF) Technology market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Multiplex Immunofluorescence (mIF) Technology market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Multiplex Immunofluorescence (mIF) Technology.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Multiplex Immunofluorescence (mIF) Technology market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Multiplex Immunofluorescence (mIF) Technology Market by Company

Eureka Biotech

ICON plc

Discovery Life Sciences

Precision Medicine Group

Terry Technologies

MGI Tech

panovue

Biospective

iCuraDx

Yucebio

Flagship Biosciences

Lanterne Dx (LDX)

Crown Bioscience

Multiplex Immunofluorescence (mIF) Technology Segment by Type

Direct Labeling mIF Technology

TSA-based Amplification mIF Technology

Dual-amplification mIF Technology

Multiplex Immunofluorescence (mIF) Technology Segment by Application

Tumor Immunology Research

Clinical Pathological Diagnosis

Immune Microenvironment Profiling

Other

Multiplex Immunofluorescence (mIF) Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Immunofluorescence (mIF) Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multiplex Immunofluorescence (mIF) Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Immunofluorescence (mIF) Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Multiplex Immunofluorescence (mIF) Technology companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Multiplex Immunofluorescence (mIF) Technology Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region (2021-2026) Table 4. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region (2027-2032) Table 6. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Multiplex Immunofluorescence (mIF) Technology Market Size Share by Type (2021-2026) Table 9. Global Multiplex Immunofluorescence (mIF) Technology Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Multiplex Immunofluorescence (mIF) Technology Market Size Share Forecasted by Type (2027-2032) Table 11. North America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Multiplex Immunofluorescence (mIF) Technology Market Size Share by Application (2021-2026) Table 24. Global Multiplex Immunofluorescence (mIF) Technology Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Multiplex Immunofluorescence (mIF) Technology Market Size Share Forecasted by Application (2027-2032) Table 26. North America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Multiplex Immunofluorescence (mIF) Technology Industry Trends Table 37. Multiplex Immunofluorescence (mIF) Technology Industry Drivers Table 38. Multiplex Immunofluorescence (mIF) Technology Industry Opportunities and Challenges Table 39. Multiplex Immunofluorescence (mIF) Technology Industry Restraints Table 40. Global Multiplex Immunofluorescence (mIF) Technology Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Company (2021-2026) Table 42. Global Multiplex Immunofluorescence (mIF) Technology Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Multiplex Immunofluorescence (mIF) Technology Key Company Headquarters & Area Served Table 44. Global Multiplex Immunofluorescence (mIF) Technology Company, Product Type & Application Table 45. Global Multiplex Immunofluorescence (mIF) Technology Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Multiplex Immunofluorescence (mIF) Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eureka Biotech Company Information Table 49. Eureka Biotech Business Overview Table 50. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 52. Eureka Biotech Recent Development Table 53. ICON plc Company Information Table 54. ICON plc Business Overview Table 55. ICON plc Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. ICON plc Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 57. ICON plc Recent Development Table 58. Discovery Life Sciences Company Information Table 59. Discovery Life Sciences Business Overview Table 60. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 62. Discovery Life Sciences Recent Development Table 63. Precision Medicine Group Company Information Table 64. Precision Medicine Group Business Overview Table 65. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 67. Precision Medicine Group Recent Development Table 68. Terry Technologies Company Information Table 69. Terry Technologies Business Overview Table 70. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 72. Terry Technologies Recent Development Table 73. MGI Tech Company Information Table 74. MGI Tech Business Overview Table 75. MGI Tech Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. MGI Tech Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 77. MGI Tech Recent Development Table 78. panovue Company Information Table 79. panovue Business Overview Table 80. panovue Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. panovue Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 82. panovue Recent Development Table 83. Biospective Company Information Table 84. Biospective Business Overview Table 85. Biospective Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biospective Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 87. Biospective Recent Development Table 88. iCuraDx Company Information Table 89. iCuraDx Business Overview Table 90. iCuraDx Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. iCuraDx Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 92. iCuraDx Recent Development Table 93. Yucebio Company Information Table 94. Yucebio Business Overview Table 95. Yucebio Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Yucebio Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 97. Yucebio Recent Development Table 98. Flagship Biosciences Company Information Table 99. Flagship Biosciences Business Overview Table 100. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 102. Flagship Biosciences Recent Development Table 103. Lanterne Dx (LDX) Company Information Table 104. Lanterne Dx (LDX) Business Overview Table 105. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 107. Lanterne Dx (LDX) Recent Development Table 108. Crown Bioscience Company Information Table 109. Crown Bioscience Business Overview Table 110. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Product Portfolio Table 112. Crown Bioscience Recent Development Table 113. North America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2026) Table 116. North America Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Multiplex Immunofluorescence (mIF) Technology Market Share Forecast by Country (2027-2032) Table 118. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2026) Table 121. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Multiplex Immunofluorescence (mIF) Technology Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2026) Table 126. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Share Forecast by Country (2027-2032) Table 128. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2026) Table 131. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Multiplex Immunofluorescence (mIF) Technology Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2026) Table 136. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Multiplex Immunofluorescence (mIF) Technology Product Image Figure 3. Global Multiplex Immunofluorescence (mIF) Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Multiplex Immunofluorescence (mIF) Technology Market Size (2021-2032) & (US$ Million) Figure 5. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region: 2025 VS 2032 Figure 6. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region (2021-2032) Figure 7. North America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Direct Labeling mIF Technology Image Figure 13. Global Direct Labeling mIF Technology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. TSA-based Amplification mIF Technology Image Figure 15. Global TSA-based Amplification mIF Technology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Dual-amplification mIF Technology Image Figure 17. Global Dual-amplification mIF Technology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Multiplex Immunofluorescence (mIF) Technology Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Type 2025 VS 2032 Figure 20. North America Multiplex Immunofluorescence (mIF) Technology Market Size Share by Type (2021-2032) Figure 21. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Share by Type (2021-2032) Figure 23. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Share by Type (2021-2032) Figure 25. Tumor Immunology Research Image Figure 26. Global Tumor Immunology Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinical Pathological Diagnosis Image Figure 28. Global Clinical Pathological Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Immune Microenvironment Profiling Image Figure 30. Global Immune Microenvironment Profiling Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Multiplex Immunofluorescence (mIF) Technology Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Application 2025 VS 2032 Figure 35. North America Multiplex Immunofluorescence (mIF) Technology Market Size Share by Application (2021-2032) Figure 36. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Share by Application (2021-2032) Figure 38. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Multiplex Immunofluorescence (mIF) Technology Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Multiplex Immunofluorescence (mIF) Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2032) Figure 45. Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Multiplex Immunofluorescence (mIF) Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2032) Figure 48. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2032) Figure 51. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Multiplex Immunofluorescence (mIF) Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2032) Figure 54. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Direct Labeling mIF Technology
  • TSA-based Amplification mIF Technology
  • Dual-amplification mIF Technology
Applications
  • Tumor Immunology Research
  • Clinical Pathological Diagnosis
  • Immune Microenvironment Profiling
  • Other
Companies covered
  • Eureka Biotech
  • ICON plc
  • Discovery Life Sciences
  • Precision Medicine Group
  • Terry Technologies
  • MGI Tech
  • panovue
  • Biospective
  • iCuraDx
  • Yucebio
  • Flagship Biosciences
  • Lanterne Dx (LDX)
  • Crown Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Multiplex Immunofluorescence (mIF) Technology Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2021-2032)
  5. 1.4.1 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2021-2026)
  6. 1.4.2 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2027-2032)
  7. 1.5 Key Regions Multiplex Immunofluorescence (mIF) Technology Market Size (2021-2032)
  8. 1.5.1 North America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (2021-2032)
2 Multiplex Immunofluorescence (mIF) Technology Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Direct Labeling mIF Technology
  3. 2.1.2 TSA-based Amplification mIF Technology
  4. 2.1.3 Dual-amplification mIF Technology
  5. 2.2 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Type
  6. 2.2.1 Global Multiplex Immunofluorescence (mIF) Technology Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Multiplex Immunofluorescence (mIF) Technology Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Multiplex Immunofluorescence (mIF) Technology Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Regions
  10. 2.3.1 North America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Type (2021-2026)
3 Multiplex Immunofluorescence (mIF) Technology Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Tumor Immunology Research
  3. 3.1.2 Clinical Pathological Diagnosis
  4. 3.1.3 Immune Microenvironment Profiling
  5. 3.1.4 Other
  6. 3.2 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Application
  7. 3.2.1 Global Multiplex Immunofluorescence (mIF) Technology Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Multiplex Immunofluorescence (mIF) Technology Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Multiplex Immunofluorescence (mIF) Technology Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Regions
  11. 3.3.1 North America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Multiplex Immunofluorescence (mIF) Technology Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Multiplex Immunofluorescence (mIF) Technology Industry Trends
  2. 4.2 Multiplex Immunofluorescence (mIF) Technology Industry Drivers
  3. 4.3 Multiplex Immunofluorescence (mIF) Technology Industry Opportunities and Challenges
  4. 4.4 Multiplex Immunofluorescence (mIF) Technology Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2026)
  2. 5.2 Global Multiplex Immunofluorescence (mIF) Technology Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Multiplex Immunofluorescence (mIF) Technology Key Company Headquarters & Area Served
  4. 5.4 Global Multiplex Immunofluorescence (mIF) Technology Company, Product Type & Application
  5. 5.5 Global Multiplex Immunofluorescence (mIF) Technology Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Multiplex Immunofluorescence (mIF) Technology Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Multiplex Immunofluorescence (mIF) Technology Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Multiplex Immunofluorescence (mIF) Technology Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eureka Biotech
  2. 6.1.1 Eureka Biotech Company Information
  3. 6.1.2 Eureka Biotech Business Overview
  4. 6.1.3 Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  6. 6.1.5 Eureka Biotech Recent Developments
  7. 6.2 ICON plc
  8. 6.2.1 ICON plc Company Information
  9. 6.2.2 ICON plc Business Overview
  10. 6.2.3 ICON plc Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 ICON plc Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  12. 6.2.5 ICON plc Recent Developments
  13. 6.3 Discovery Life Sciences
  14. 6.3.1 Discovery Life Sciences Company Information
  15. 6.3.2 Discovery Life Sciences Business Overview
  16. 6.3.3 Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  18. 6.3.5 Discovery Life Sciences Recent Developments
  19. 6.4 Precision Medicine Group
  20. 6.4.1 Precision Medicine Group Company Information
  21. 6.4.2 Precision Medicine Group Business Overview
  22. 6.4.3 Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  24. 6.4.5 Precision Medicine Group Recent Developments
  25. 6.5 Terry Technologies
  26. 6.5.1 Terry Technologies Company Information
  27. 6.5.2 Terry Technologies Business Overview
  28. 6.5.3 Terry Technologies Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Terry Technologies Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  30. 6.5.5 Terry Technologies Recent Developments
  31. 6.6 MGI Tech
  32. 6.6.1 MGI Tech Company Information
  33. 6.6.2 MGI Tech Business Overview
  34. 6.6.3 MGI Tech Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 MGI Tech Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  36. 6.6.5 MGI Tech Recent Developments
  37. 6.7 panovue
  38. 6.7.1 panovue Company Information
  39. 6.7.2 panovue Business Overview
  40. 6.7.3 panovue Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 panovue Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  42. 6.7.5 panovue Recent Developments
  43. 6.8 Biospective
  44. 6.8.1 Biospective Company Information
  45. 6.8.2 Biospective Business Overview
  46. 6.8.3 Biospective Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biospective Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  48. 6.8.5 Biospective Recent Developments
  49. 6.9 iCuraDx
  50. 6.9.1 iCuraDx Company Information
  51. 6.9.2 iCuraDx Business Overview
  52. 6.9.3 iCuraDx Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 iCuraDx Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  54. 6.9.5 iCuraDx Recent Developments
  55. 6.10 Yucebio
  56. 6.10.1 Yucebio Company Information
  57. 6.10.2 Yucebio Business Overview
  58. 6.10.3 Yucebio Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Yucebio Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  60. 6.10.5 Yucebio Recent Developments
  61. 6.11 Flagship Biosciences
  62. 6.11.1 Flagship Biosciences Company Information
  63. 6.11.2 Flagship Biosciences Business Overview
  64. 6.11.3 Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  66. 6.11.5 Flagship Biosciences Recent Developments
  67. 6.12 Lanterne Dx (LDX)
  68. 6.12.1 Lanterne Dx (LDX) Company Information
  69. 6.12.2 Lanterne Dx (LDX) Business Overview
  70. 6.12.3 Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  72. 6.12.5 Lanterne Dx (LDX) Recent Developments
  73. 6.13 Crown Bioscience
  74. 6.13.1 Crown Bioscience Company Information
  75. 6.13.2 Crown Bioscience Business Overview
  76. 6.13.3 Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Product Portfolio
  78. 6.13.5 Crown Bioscience Recent Developments
7 North America
  1. 7.1 North America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026)
  3. 7.3 North America Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026)
  3. 8.3 Europe Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026)
  3. 10.3 South America Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst